Wright Medical Group Inc  

(Public, NASDAQ:WMGI)   Watch this stock  
Find more results for Wright Medical Group Inc´┐Ż
+0.03 (0.13%)
Real-time:   1:54PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.50 - 25.89
52 week 23.56 - 32.65
Open 25.72
Vol / Avg. 156,558.00/517,680.00
Mkt cap 1.32B
P/E     -
Div/yield     -
EPS -4.74
Shares 51.42M
Beta 0.53
Inst. own 122%
Oct 29, 2015
Q3 2015 Wright Medical Group Inc Earnings Call - Tentative - 4:30PM EDT - Add to calendar
Oct 29, 2015
Q3 2015 Wright Medical Group Inc Earnings Release - Tentative Add to calendar
Sep 10, 2015
Wright Medical Group Inc at Wells Fargo Healthcare Conference - 9:45AM EDT - Add to calendar
Sep 9, 2015
Wright Medical Group Inc at Robert W Baird and Co Health Care Conference - 10:15AM EDT - Add to calendar
Jul 29, 2015
Q2 2015 Wright Medical Group Inc Earnings Call - Webcast
Jul 29, 2015
Q2 2015 Wright Medical Group Inc Earnings Release
Jun 18, 2015
Wright Medical Group Inc Extraordinary Shareholders Meeting
Jun 2, 2015
Wright Medical Group Inc at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -46.39% -80.70%
Operating margin -42.70% -33.49%
EBITD margin - -17.18%
Return on average assets -12.61% -25.31%
Return on average equity -65.31% -65.13%
Employees 1,180 -
CDP Score - -


5677 Airline Rd
ARLINGTON, TN 38002-9501
United States - Map
+1-901-8679971 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients' lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Company's business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company's products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.

Officers and directors

David D. Stevens Independent Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Peter Cooke President - International
Age: 49
Bio & Compensation  - Reuters
Robert J. Palmisano President, Chief Executive Officer, Director
Age: 70
Bio & Compensation  - Reuters
Lance A. Berry Chief Financial Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Kevin D. Cordell President - U.S. Extremities
Age: 49
Bio & Compensation  - Reuters
Pascal E.R. Girin Chief Operating Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Jason R. Senner Chief Human Resource Officer, Senior Vice President
Age: 48
Bio & Compensation  - Reuters
J.Wesley Porter Senior Vice President, Chief Compliance Officer
Age: 45
Bio & Compensation  - Reuters
James A. Lightman Senior Vice President, General Counsel, Secretary
Age: 57
Bio & Compensation  - Reuters
Julie D Tracy MBA Senior Vice President, Chief Communications Officer
Age: 53
Bio & Compensation  - Reuters